Hefty Payouts Won’t Change Big Pharma’s Actions Unless Major Reforms Are Made

-7 out of 10 Americans take at least one prescription medication.

-20%, or $3.5 trillion, of the GDP (Gross Domestic Product) goes towards health care costs.

-In a single year, one drug company spent over $460 million in advertising for its blood thinner Pradaxa.

clinical trialsMorgan Statt – These statistics, laid out by the American Intelligence Media in an article entitled Pharmageddon, highlight one undeniable fact. Big Pharma is Big Business. Patients’ health and safety is often cast aside to make room for manufacturers to focus on one thing: profits.

Suffice to say that money is blinding. Flashing dollar signs can distract even the most ethical of individuals and sway them to cross the line between right and wrong. In the case of Big Pharma, these distractions and abandonment of ethics don’t just impact a manufacturer’s bottom line.

When a pharmaceutical manufacturer places profit at the forefront of its priorities, the very patients boosting the company’s profit margin may suffer severe injuries and in some cases death that is caused by a drug’s side effects. Continue reading